BelgiumOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 459 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72,167 | 55,853 |
| Total Cites | 4,534 | 6,476 |
| H-index | 33 | 38 |
| Hm-index | 20 | 24 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 246 | 282 |
| Number of Single+First Authored Papers | 159 | 159 |
| Total Cites to Single+First Authored Papers | 1,208 | 1,629 |
| Number of Single+First+Last Authored Papers | 427 | 427 |
| Total Cites to Single+First+Last Authored Papers | 3,942 | 5,680 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,031 | 4,462 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.45 |
| Self-Citation Percentage |
29.99%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 441 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69,901 | 53,931 |
| Total Cites | 4,150 | 6,057 |
| H-index | 32 | 37 |
| Hm-index | 19 | 23 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 237 | 272 |
| Number of Single+First Authored Papers | 157 | 157 |
| Total Cites to Single+First Authored Papers | 1,148 | 1,566 |
| Number of Single+First+Last Authored Papers | 414 | 414 |
| Total Cites to Single+First+Last Authored Papers | 3,644 | 5,355 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,686 | 4,110 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.47 |
| Self-Citation Percentage |
31.48%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 441 out of 49,699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69,576 | 52,815 |
| Total Cites | 4,035 | 5,922 |
| H-index | 31 | 37 |
| Hm-index | 19 | 22 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 233 | 267 |
| Number of Single+First Authored Papers | 157 | 157 |
| Total Cites to Single+First Authored Papers | 1,115 | 1,528 |
| Number of Single+First+Last Authored Papers | 416 | 416 |
| Total Cites to Single+First+Last Authored Papers | 3,544 | 5,237 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,578 | 3,994 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.48 |
| Self-Citation Percentage |
31.86%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 432 out of 41,196 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66,295 | 49,543 |
| Total Cites | 3,712 | 5,581 |
| H-index | 30 | 35 |
| Hm-index | 18 | 22 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 223 | 257 |
| Number of Single+First Authored Papers | 158 | 158 |
| Total Cites to Single+First Authored Papers | 1,057 | 1,470 |
| Number of Single+First+Last Authored Papers | 418 | 418 |
| Total Cites to Single+First+Last Authored Papers | 3,329 | 5,009 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,277 | 3,694 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.51 |
| Self-Citation Percentage |
33.49%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.